SEARCH

SEARCH BY CITATION

References

  • 1
    Reaven, GM. (1988) Banting Lecture, 1988. Role of insulin resistance in human disease. Diabetes. 37: 15951607.
  • 2
    Kahn, B. B., Flier, J. (2000) Obesity and insulin resistance. J Clin Invest. 106: 473481.
  • 3
    Stern, MP. (2000) Strategies and prospect for finding insulin resistance genes. J Clin Invest. 106: 323327.
  • 4
    Almind, K., Doria, A., Kahn, CR. (2001) Putting the genes for type II diabetes on the map. Nat Med. 7: 277279.
  • 5
    Weinstein, S. P., O'Boyle, E., Haber, RS. (1994) Thyroid hormone increases basal and insulin stimulated glucose transport in skeletal muscle: the role of GLUT4 glucose transporter expression. Diabetes. 43: 11851189.
  • 6
    Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., Larsen, PR. (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 23: 3889.
  • 7
    Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., et al (2002) Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance. Diabetes. 51: 880883.
  • 8
    Canani, L. H., Capp, C., Dora, J. M., et al (2005) The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 90: 34723478.
  • 9
    Grarup, N., Andersen, M. K., Andreasen, C. H., et al (2007) Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J Clin Endocrinol Metab. 92: 363366.
  • 10
    Stumvoll, M., Haring, H. (2002) The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes. 51: 23412347.
  • 11
    Masugi, J., Tamori, Y., Mori, H., Koike, T., Kasuga, M. (2000) Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun. 268: 178182.
  • 12
    Gumieniak, O., Perlstein, T. S., Williams, J. S., et al (2007) Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension. 3: 461466.
  • 13
    Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285: 24862497.
  • 14
    Moore, JH. (2004) Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn. 4: 795803.
  • 15
    Colin, N., Palmer, C. N., Hsu, M. H., Griffin, H. J., Johnson, EF. (1995) Novel sequence determinants in peroxisome proliferator signalling. J Biol Chem. 270: 1611416121.
  • 16
    Kondo, H., Shimomura, I., Kishida, K., et al (2002) Human aquaporin adipose (AQPap) gene: genomic structure, promoter analysis and functional mutation. Eur J Biochem. 269: 18141826.
  • 17
    Torrance, C. J., Devente, J. E., Jones, J. O., Dohm, GL. (1995) Effects of thyroid hormone on GLUT 4 glucose transporter gene expression and NIDDM in rats. Endocrinology. 138: 12041214.
  • 18
    Richardson, J. M., Pessin, JE. (1993) Identification of a skeletal muscle-specific regulatory domain in the rat GLUT4/muscle-fat gene. J Biol Chem. 268: 2102121027.
  • 19
    De Cosmo, S., Trevisan, R., Minenna, A., et al (2006) Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes. Diabetes Care. 29: 432434.
  • 20
    Baratta, R., Di Paola, R., Spampinato, D., et al (2003) Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms. J Mol Med. 81: 718723.
  • 21
    Amati, F., Conti, E., Botta, A., Amicucci, P., Dallapiccola, B., Novelli, G. (2002) Functional characterization of the 5′ flanking region of human ubiquitin fusion degradation 1 like gene (UFD1L). Cell Biochem Funct. 20: 163170.